Moleculin Biotech Inc

NASDAQ:MBRX   2:20:01 PM EDT
2.96
+0.01 (+0.34%)
Earnings Announcements

Moleculin Reports Q2 Financial Results

Published: 08/12/2021 12:45 GMT
Moleculin Biotech Inc (MBRX) - Moleculin Reports Second Quarter 2021 Financial Results and Provides Programs Update.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.20

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.21

More details on our Analysts Page.